What does Pharmacie Pharmavie Gilly do?

Pharmacie Pharmavie Gilly is a logistics company in Charleroi. Private Limited, started on 12 November 2002, 1 establishment.

What is the address of Pharmacie Pharmavie Gilly?

The registered office of Pharmacie Pharmavie Gilly is located at Rue Noir Dieu 9, 6060 Charleroi.

Is Pharmacie Pharmavie Gilly still active?

Yes. According to the CBE (17 September 2026) Pharmacie Pharmavie Gilly is active, legal situation “Normale toestand”, started on 12 November 2002.

Is Pharmacie Pharmavie Gilly registered on Peppol?

Yes, Pharmacie Pharmavie Gilly is registered on the Peppol network with ID 0208:0478753891.

What is the enterprise number of Pharmacie Pharmavie Gilly?

The enterprise number of Pharmacie Pharmavie Gilly is BE0478753891.

When was Pharmacie Pharmavie Gilly founded?

Pharmacie Pharmavie Gilly was founded on 12 November 2002.

Who are the directors of Pharmacie Pharmavie Gilly?

According to the 2025 annual accounts, the directors of Pharmacie Pharmavie Gilly are: PHARMACIE BLONDEAU - VANDER CASSYEN SRL.

Is Pharmacie Pharmavie Gilly a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 November 2002; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Pharmacie Pharmavie Gilly make in 2025?

Pharmacie Pharmavie Gilly posted a profit after taxes of € 18,111 in financial year 2025.

What is the revenue of Pharmacie Pharmavie Gilly?

As a small company, Pharmacie Pharmavie Gilly is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 447,868.

How much does an employee at Pharmacie Pharmavie Gilly earn?

The average wage cost per full-time employee at Pharmacie Pharmavie Gilly was € 106,100 in 2025: staff costs of € 328,912 for 3.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Pharmacie Pharmavie Gilly have?

According to the 2025 annual accounts, Pharmacie Pharmavie Gilly has 3.1 full-time equivalents (FTE).

Does Pharmacie Pharmavie Gilly have a website?

Yes, Pharmacie Pharmavie Gilly has a website at pharmacie-tergolina.be.

Pharmacie Pharmavie Gilly (Private Limited) - Charleroi

Dossier Pharmacie Pharmavie Gilly, printed on 17 September 2026 from databakkes.be/en/0478753891/pharmacie-pharmavie-gilly. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Pharmacie Pharmavie Gilly from Charleroi, company number BE0478753891, closed financial year 2025 with a result of € 18,111 after tax. For that financial year Pharmacie Pharmavie Gilly recorded a gross margin of € 447,868 and equity of € 220,956. Compared with financial year 2024, the result moved from € 26,184 to € 18,111. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 220,956

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 18,111

▼ 31% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 40,674

▲ 37% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 202,406.

People and assets in 2025

Full-time equivalents

3.1

▲ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 328,912

▲ 50% vs 2024

€ 106,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,029

▲ 49% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 40,860

▲ 36% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 169,741

▲ 29% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 48,163

▲ 28% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 140,436 Gross margin 2022: € 140,436 First fiscal year in the series	€ 222,199 Gross margin 2023: € 222,199 ▲ 58% vs 2022 (€ 140,436) Favourable step	€ 261,793 Gross margin 2024: € 261,793 ▲ 18% vs 2023 (€ 222,199) Favourable step	€ 447,868 Gross margin 2025: € 447,868 ▲ 71% vs 2024 (€ 261,793) Favourable step	▲ 71%
Profit after taxes	€ 37,555 Profit after taxes 2022: € 37,555 First fiscal year in the series	€ -16,428 Profit after taxes 2023: € -16,428 ▼ € 53,983 vs 2022 (€ 37,555) Unfavourable step	€ 26,184 Profit after taxes 2024: € 26,184 ▲ € 42,612 vs 2023 (€ -16,428) Favourable step	€ 18,111 Profit after taxes 2025: € 18,111 ▼ 31% vs 2024 (€ 26,184) Unfavourable step	▼ 31%
Equity	€ 243,252 Equity 2022: € 243,252 First fiscal year in the series	€ 226,661 Equity 2023: € 226,661 ▼ 7% vs 2022 (€ 243,252) Unfavourable step	€ 202,845 Equity 2024: € 202,845 ▼ 11% vs 2023 (€ 226,661) Unfavourable step	€ 220,956 Equity 2025: € 220,956 ▲ 9% vs 2024 (€ 202,845) Favourable step	▲ 9%
Total debts	€ 225,224 Total debts 2022: € 225,224 First fiscal year in the series	€ 215,041 Total debts 2023: € 215,041 ▼ 5% vs 2022 (€ 225,224) Favourable step	€ 199,000 Total debts 2024: € 199,000 ▼ 7% vs 2023 (€ 215,041) Favourable step	€ 292,502 Total debts 2025: € 292,502 ▲ 47% vs 2024 (€ 199,000) Unfavourable step	▲ 47%
Cash	€ 74,741 Cash 2022: € 74,741 First fiscal year in the series	€ 42,658 Cash 2023: € 42,658 ▼ 43% vs 2022 (€ 74,741) Unfavourable step	€ 29,764 Cash 2024: € 29,764 ▼ 30% vs 2023 (€ 42,658) Unfavourable step	€ 40,674 Cash 2025: € 40,674 ▲ 37% vs 2024 (€ 29,764) Favourable step	▲ 37%
Land & buildings	€ 152,361 Land & buildings 2022: € 152,361 First fiscal year in the series	€ 144,593 Land & buildings 2023: € 144,593 ▼ 5% vs 2022 (€ 152,361) Unchanged	€ 136,825 Land & buildings 2024: € 136,825 ▼ 5% vs 2023 (€ 144,593) Unchanged	€ 123,230 Land & buildings 2025: € 123,230 ▼ 10% vs 2024 (€ 136,825) Unchanged	▼ 10%
Retained profit	€ 224,539 Retained profit 2022: € 224,539 First fiscal year in the series	€ 208,111 Retained profit 2023: € 208,111 ▼ 7% vs 2022 (€ 224,539) Unfavourable step	€ 184,295 Retained profit 2024: € 184,295 ▼ 11% vs 2023 (€ 208,111) Unfavourable step	€ 202,406 Retained profit 2025: € 202,406 ▲ 10% vs 2024 (€ 184,295) Favourable step	▲ 10%
Dividend	€ 50,000 Dividend 2022: € 50,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 50,000) Unchanged	€ 50,000 Dividend 2024: € 50,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 50,000) Unchanged	▼ 100%
Bank debt	€ 18,699 Bank debt 2022: € 18,699 First fiscal year in the series	€ 45,000 Bank debt 2023: € 45,000 ▲ 141% vs 2022 (€ 18,699) Unfavourable step	€ 30,000 Bank debt 2024: € 30,000 ▼ 33% vs 2023 (€ 45,000) Favourable step	€ 40,860 Bank debt 2025: € 40,860 ▲ 36% vs 2024 (€ 30,000) Unfavourable step	▲ 36%
Balance sheet total	€ 468,476 Balance sheet total 2022: € 468,476 First fiscal year in the series	€ 441,701 Balance sheet total 2023: € 441,701 ▼ 6% vs 2022 (€ 468,476) Unchanged	€ 401,845 Balance sheet total 2024: € 401,845 ▼ 9% vs 2023 (€ 441,701) Unchanged	€ 513,458 Balance sheet total 2025: € 513,458 ▲ 28% vs 2024 (€ 401,845) Unchanged	▲ 28%
Employees (FTE)	1.6 Employees (FTE) 2022: 1.6 First fiscal year in the series	2.4 Employees (FTE) 2023: 2.4 ▲ 0.8 vs 2022 (1.6) Unchanged	2.6 Employees (FTE) 2024: 2.6 ▲ 0.2 vs 2023 (2.4) Unchanged	3.1 Employees (FTE) 2025: 3.1 ▲ 0.5 vs 2024 (2.6) Unchanged	▲ 0.5

Key figures of Pharmacie Pharmavie Gilly, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Pharmacie Pharmavie Gilly?

What happened at Pharmacie Pharmavie Gilly in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 18,111 (▼ 31% vs 2024). filed late Source: NBB ↗
2025 PHARMACIE BLONDEAU - VANDER CASSYEN SRL became a director. NBB
Dec 9, 2002 New establishment in Charleroi. KBO
Nov 12, 2002 Start of the company according to the CBE. KBO

In short

From € 37,555 profit in 2022 to € 18,111 profit in 2025.

Paid € 23,726 in corporate taxes since 2022.

Best year ever: 2022, with € 37,555 profit.

On average € 144,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at Pharmacie Pharmavie Gilly? We notify you, reason included.

Follow Pharmacie Pharmavie Gilly

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

PHARMACIE BLONDEAU - VANDER CASSYEN 100%

The stake of PHARMACIE BLONDEAU - VANDER CASSYEN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Pharmacie Pharmavie Gilly

Behind Pharmacie Pharmavie Gilly is PHARMACIE BLONDEAU - VANDER CASSYEN SRL. The shares are held by PHARMACIE BLONDEAU - VANDER CASSYEN (100%).

See the full network in the app

Directors

According to the 2025 annual accounts

PHARMACIE BLONDEAU - VANDER CASSYEN SRL

Director · represented by VIRGINIE VANDERCASSYEN

Also active at: PHALADEL, PHARMACIE PHARMAVIE HARCHIES, PHARMACIE PHARMAVIE LE ROEULX, PHARMACIE PHARMAVIE THIEU, Pharmacie GLORIEUX

since 2025

Shareholders

PHARMACIE BLONDEAU - VANDER CASSYEN

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Noir Dieu 9

6060 Charleroi

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS pharmacie-tergolina.be

Canonical: https://www.pharmacie-tergolina.be/

Technologies

ElementorMatomoPHPWooCommerceWordPressYoast SEOjQuery

Hosting & Email

Email provider

Self-hosted

Hosting

O2SWITCH, FR

Domain

pharmacie-tergolina.be

Registered

2026-02-09

Website info

HTTPS Ja

Languages FR

Features

Webshop

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number

0478.753.891

VAT number

BE 0478.753.891

Registered office

Rue Noir Dieu 9, 6060 Charleroi

Names & denominations

Pharmacie Pharmavie Gilly

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

12 November 2002

Peppol

Active · Active since 11 Dec 2025

Contact

pharmacie-tergolina.be 0473500714

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

Pharmacie Pharmavie Gilly

Financials

What happened to Pharmacie Pharmavie Gilly?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Details

Frequently asked questions